Antibody-dependent enhancement of yellow fever and Japanese encephalitis virus neurovirulence.
about
Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for preventionFeasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplexLethal antibody enhancement of dengue disease in mice is prevented by Fc modificationCharacterization of a siberian virus isolated from a patient with progressive chronic tick-borne encephalitis.Isolation and Characterization of Human Monoclonal Antibodies from Individuals Infected with West Nile VirusPre- and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse modelComplement Protein C1q Inhibits Antibody-Dependent Enhancement of Flavivirus Infection in an IgG Subclass-Specific MannerMonoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virusLive Chimeric and Inactivated Japanese Encephalitis Virus Vaccines Differ in Their Cross-Protective Values against Murray Valley Encephalitis VirusThe Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus InfectionMolecular mechanisms of antibody-mediated neutralisation of flavivirus infectionProgress on the development of therapeutics against West Nile virusEvasion of innate and adaptive immunity by flavivirusesA Japanese Encephalitis Virus Vaccine Inducing Antibodies Strongly Enhancing In Vitro Infection Is Protective in PigsMeta-analysis of all immune epitope data in the Flavivirus genus: inventory of current immune epitope data status in the context of virus immunity and immunopathology.Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virusThe NS1 glycoprotein can generate dramatic antibody-enhanced dengue viral replication in normal out-bred mice resulting in lethal multi-organ disease.A humanized IgG but not IgM antibody is effective in prophylaxis and therapy of yellow fever infection in an AG129/17D-204 peripheral challenge mouse modelDevelopment of effective therapies against West Nile virus infection.Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development.Biomarkers in Japanese encephalitis: a review.A Structural and Mathematical Modeling Analysis of the Likelihood of Antibody-Dependent Enhancement in Influenza.Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice.Immunisation with gamma globulin to murray valley encephalitis virus and with an inactivated Japanese encephalitis virus vaccine as prophylaxis against australian encephalitis: evaluation in a mouse model.Biomimetic inorganic camouflage circumvents antibody-dependent enhancement of infection.Flavivirus serocomplex cross-reactive immunity is protective by activating heterologous memory CD4 T cells.Japanese Encephalitis Virus Generated Neurovirulence, Antigenicity, and Host Immune ResponsesImmunopathogenesis of hepatitis C virus infection
P2860
Q24684689-5BB52DC8-E95D-42A2-89C9-5CEB74A5F0CAQ24737461-0DBBF899-8C2E-44AC-BFA4-9BC87F370E1CQ27315772-D14ED3ED-8800-4EB9-94D2-F3D4394B853DQ27473070-FBD5DC04-5AC2-4E7D-918F-BEBBCD081F90Q27473288-91863747-D18E-406B-AED2-B9B9C8914A4CQ27480808-9EBA5028-D78A-49B2-8A49-D3D2FA9DBFFEQ27485131-C18E8ECD-BD39-4BD7-B152-50B3E6623729Q27486190-68990C0B-2725-4C12-A4D1-84633A6C9681Q27487967-3754FBA1-0656-4B31-A0FB-B2C99624A594Q27488224-F9FDCA9E-ADF6-440A-AF6F-8EEE946C560BQ27488337-727C8A66-631D-456D-9DC4-FC8E49E01AA1Q27489893-CB814322-4EF1-4118-90F1-A2798ADEBC03Q28204656-1FA09D22-6C6D-49A1-B43E-9F031375E760Q30250935-818AA2E1-4F5B-4299-8879-750B070ED0FDQ33610555-B9BA2153-A60A-41CF-8A41-8252DD65D4C0Q33850577-EFD412D0-8DD4-4C76-B2F4-E4B220D45D57Q33952146-F71FE184-4000-4C36-991C-7E5DE73714DFQ35903209-2E8D3FCB-61E7-4A3A-8B2F-D086DBDB1C07Q36322125-CDCBB56D-6530-4A54-9860-E527AC2A4D14Q36780133-C807310E-720B-4592-AF91-3304D5FA4BF9Q37425963-E73FB2B5-AA2E-48AC-81AE-E110FF899C16Q38983251-1FD3F689-0DD3-4D98-A44E-92ADD67D52E6Q40344535-1C00B5E3-056B-404C-A0B2-52217892139FQ42998519-953E9FB3-C809-4809-AE93-5AC701D89955Q53427852-AAF2A6BD-447A-4C5C-93AF-1700F930B7EBQ55519030-389EE8B7-5DE7-4344-BC7F-70BAA2C13E78Q58999704-43149180-A3CA-47E7-BF32-97DDB1827454Q59200582-5D3D5900-586B-47A0-ACE8-C0BAF738F42A
P2860
Antibody-dependent enhancement of yellow fever and Japanese encephalitis virus neurovirulence.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Antibody-dependent enhancement ...... phalitis virus neurovirulence.
@en
type
label
Antibody-dependent enhancement ...... phalitis virus neurovirulence.
@en
prefLabel
Antibody-dependent enhancement ...... phalitis virus neurovirulence.
@en
P921
P1476
Antibody-dependent enhancement ...... phalitis virus neurovirulence.
@en
P2093
P304
P356
10.1099/0022-1317-70-6-1605
P407
P478
70 ( Pt 6)
P577
1989-06-01T00:00:00Z